Page 1 of 1

Circassia (CIR)

Posted: December 17th, 2019, 3:48 am
by Proselenes
I found the write up quite compelling and Richard Griffiths is no mug and now the largest holder, certainly worth having some. in my view.

The write up was from Finncap in September, PDF download link below:

https://ufile.io/u2v6r5ve

.

Web site is https://www.circassia.com/

Currently some insti selling and others buying. Looks primed now for cash generation in 2020 and moving to profits in 2021. No need for any further fund raising. Products in Respiratory area, which is fast growing in some aspects of their business due to all the air pollution around now.

Certainly a good idea for a share to hold for the coming couple of years, significant potential in my view.

Re: Circassia (CIR)

Posted: December 29th, 2019, 8:29 pm
by schober
Some interesting comment on the two allergy failures in 2016/17
https://pharmaphorum.com/views-and-anal ... -grainger/

Re: Circassia (CIR)

Posted: January 9th, 2020, 7:40 am
by Proselenes

Re: Circassia (CIR)

Posted: January 9th, 2020, 7:43 am
by Proselenes
Comment from Finncap.


Morning Note 9 January 2020

Circassia issued a positive trading update for the year to 31 December 2019, with revenues expected to be in the middle of its £60-65m guidance range and in line with our forecasts. Year-end cash was c.£11m higher than our expectations at £27m, due to working capital timing (delayed payment for Tudorza and Duaklir inventory and boosted by third-party rebates). Stripping out these timing effects, there was a modest H2 2019 cash outflow (we estimate to have been c.£5m), which nevertheless contrasts starkly with the £20m outflow in H1 and underpins our view that the business will be EBITDA positive in 2020. We reiterate our target price of 80p, which is supported by premium revenue growth (2-year CAGR of 30%), cash generation and deleveraging balance sheet

.

Re: Circassia (CIR)

Posted: January 9th, 2020, 10:20 am
by Proselenes
Broker update (PDF file):

https://ufile.io/oxb7jswv

.

Re: Circassia (CIR)

Posted: January 10th, 2020, 10:39 am
by Proselenes
NIOX sales in China were up nearly 200% at the interims, massive growth there.

And the new version will also enhance more sales growth moving forward.

https://www.nsmedicaldevices.com/analys ... diagnosis/

.

Re: Circassia (CIR)

Posted: January 10th, 2020, 4:02 pm
by Proselenes
Nice to see.

Assume that its more of the Invesco overhang being cleared.

https://www.investegate.co.uk/cip-merch ... 18334967Z/

.